Colesevelam is a acerbity acerbic sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo beneath the cast name Welchol and abroad by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.
Colesevelam is adumbrated as an accessory to diet and exercise to abate animated low-density lipoprotein cholesterol (LDL-C) in patients with primary hyperlipidemia as monotherapy and to advance glycemic ascendancy in adults with blazon 2 diabetes mellitus,including in aggregate with a statin. The broadcast use of colesevelam in adults with blazon 2 diabetes mellitus is an archetype of biologic repositioning.
Colesevelam is one of the bile-acid sequestrants, which forth with niacin and the statins are the three capital types of cholesterol-lowering agents. The statins are advised the first-line agents. This is because of the beyond physique of affirmation acknowledging statins' adeptness to anticipate cardiovascular disease, as able-bodied as the arresting ancillary furnishings from the added two types, including bloating and ache (bile-acid sequestrants) and derma bloom (niacin). These ancillary furnishings generally advance to low accommodating compliance.
Colesevelam can be acclimated instead of cholestyramine in appropriate abiding diarrhea due to acerbity alkali malabsorption (bile acerbic diarrhea) or in the postcholecystectomy syndrome.
More about:Colesevelam manufacturer
From:Natural herbal extracts